The Efficacy and Safety of Remimazolam Besylate Combined with Esketamine for Outpatient Colonoscopy: A Prospective, Randomized, Controlled Clinical Trial
- PMID: 37746114
- PMCID: PMC10516197
- DOI: 10.2147/DDDT.S425860
The Efficacy and Safety of Remimazolam Besylate Combined with Esketamine for Outpatient Colonoscopy: A Prospective, Randomized, Controlled Clinical Trial
Abstract
Purpose: Evaluate the efficacy and safety of remimazolam besylate combined with esketamine for outpatient colonoscopy.
Patients and methods: A total of 150 outpatients undergoing colonoscopy were randomized into two groups. A MOAA/S score ≤3 was maintained. The primary outcome was the rate of successful colonoscopy completion. Time indicators, hemodynamic parameters, the consumption of lidocaine, esketamine, propofol and remimazolam besylate, MOAA/S scores and bispectral index (BIS) values, the lowest SpO2, body movement, the use of rescue medication, endoscopist and patient satisfaction, recall of the procedure, mini-mental state examination (MMSE), fatigue level and adverse events were recorded.
Results: Procedure completion was equivalent between groups (P > 0.05). Both induction and awakening times were significantly shorter in the P group (P < 0.05). There were no significant differences in colonoscopy time and discharge time (P > 0.05). The lowest SpO2 was significantly lower in the P group, while the level of fatigue was higher (P < 0.05). Patient satisfaction was significantly higher in the R group (P < 0.05). Endoscopist satisfaction was significantly higher in the P group (P < 0.05). There were no significant differences in both systolic and diastolic blood pressure between groups except at T5 and T6 (P > 0.05). Both HR and RR were significantly lower in the P group from T3 to T5 (P < 0.05). BIS values were significantly lower in the P group from T3 to T5, while MOAA/S was significantly lower in the P group at T3 and T4 (P < 0.05). Pain on injection was significantly higher in the P group (P < 0.05).
Conclusion: Remimazolam besylate has a similar efficacy to propofol when combined with subanesthetic doses of esketamine during outpatient colonoscopy. Remimazolam besylate combined with esketamine resulted in less injection pain and more stable hemodynamics, although it prolonged induction and awakening time.
Keywords: colonoscopy; esketamine; propofol; remimazolam besylate.
© 2023 Li et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Comparison of the Safety and Efficacy of Remimazolam and Propofol for Sedation in Adults Undergoing Colonoscopy: A Meta-Analysis of Randomized Controlled Trials.Medicina (Kaunas). 2025 Apr 1;61(4):646. doi: 10.3390/medicina61040646. Medicina (Kaunas). 2025. PMID: 40282937 Free PMC article.
-
The effects of remimazolam combined with sufentanil on respiration, circulation and sedation level in patients undergoing colonoscopy.BMC Anesthesiol. 2024 Jul 25;24(1):252. doi: 10.1186/s12871-024-02644-0. BMC Anesthesiol. 2024. PMID: 39054423 Free PMC article. Clinical Trial.
-
The Efficacy and Safety of Remimazolam Tosilate versus Etomidate-Propofol in Elderly Outpatients Undergoing Colonoscopy: A Prospective, Randomized, Single-Blind, Non-Inferiority Trial.Drug Des Devel Ther. 2021 Nov 16;15:4675-4685. doi: 10.2147/DDDT.S339535. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34819721 Free PMC article. Clinical Trial.
-
Safety and efficacy of remimazolam besylate in patients undergoing colonoscopy: A multicentre, single-blind, randomized, controlled, phase Ⅲ trial.Front Pharmacol. 2022 Oct 5;13:900723. doi: 10.3389/fphar.2022.900723. eCollection 2022. Front Pharmacol. 2022. PMID: 36278187 Free PMC article.
-
Comparison of remimazolam and propofol about safety outcome indicators during general anesthesia in surgical patients: a systematic review and meta-analysis.Minerva Anestesiol. 2023 Jun;89(6):553-564. doi: 10.23736/S0375-9393.23.17034-9. Epub 2023 Feb 27. Minerva Anestesiol. 2023. PMID: 36852570
Cited by
-
Comparative Analysis of Hemodynamic Effects of Remimazolam and Propofol Combined with Esketamine in Colonoscopic Procedures in the Elderly.Drug Des Devel Ther. 2024 Nov 19;18:5269-5280. doi: 10.2147/DDDT.S490179. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39588393 Free PMC article. Clinical Trial.
-
The 50% effective dose of remimazolam combined with different doses of esketamine for painless gastroscopy.Sci Rep. 2025 Apr 14;15(1):12770. doi: 10.1038/s41598-025-97649-1. Sci Rep. 2025. PMID: 40229355 Free PMC article. Clinical Trial.
-
Efficacy of esketamine in alleviating emergence delirium and agitation in pediatric patients undergoing adenotonsillectomy under general anesthesia.Am J Transl Res. 2025 Jul 15;17(7):5072-5080. doi: 10.62347/ZTBY3635. eCollection 2025. Am J Transl Res. 2025. PMID: 40821089 Free PMC article.
-
Comparison of the Safety and Efficacy of Remimazolam and Propofol for Sedation in Adults Undergoing Colonoscopy: A Meta-Analysis of Randomized Controlled Trials.Medicina (Kaunas). 2025 Apr 1;61(4):646. doi: 10.3390/medicina61040646. Medicina (Kaunas). 2025. PMID: 40282937 Free PMC article.
-
Comparison of Remimazolam-Flumazenil versus Propofol for Recovery from General Anesthesia: A Systematic Review and Meta-Analysis.J Clin Med. 2023 Nov 26;12(23):7316. doi: 10.3390/jcm12237316. J Clin Med. 2023. PMID: 38068368 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous